Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04086264 |
|---|---|
| Brief Title: | IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia |
| First Submitted : | September 9, 2019 |
| First Submitted that Met QC Criteria : | September 10, 2019 |
| First Posted : | September 11, 2019 |
| Last Update Submitted that Met QC Criteria : | April 16, 2024 |
| Last Update Posted : | April 18, 2024 |